UBS analyst Joshua Spector downgraded Xylem (NYSE: XYL) from Buy to Neutral with a price target of $132.00 (from $152.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE